EUVIMEDEUVIMED entdecken
Crossref

Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions

Akshay Binayke iD, Rajdeep Dalal, Charu Suri, Jyotsna Dandotiya, Srikanth Sadhu, Yashwant Kumar, Shailendra Asthana, Deepak Kumar Rathore, Amit Awasthi iD

European Journal of Immunology · 2025

DOI: 10.1002/eji.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Akshay Binayke und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Core Laboratory, Translational Health Science and Technology Institute, Faridabad, India. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 1, Group F, Member 3, Testosterone, Interleukin-17, Th17 Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Translational Health Science and Technology Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Th17 cells play a crucial role in autoimmune disease pathogenesis. However, the mechanisms behind the sex differences in immune responses, particularly women's higher susceptibility to autoimmune diseases, remain unclear. This study investigated the role of testosterone in modulating the IL‐17 response. IL‐17 levels and IL‐17‐expressing cells were compared between males and females, and testosterone's effect on Th17 differentiation was evaluated. In an imiquimod‐induced psoriasis mouse model, testosterone supplementation reduced psoriasis severity in female mice, whereas castration of male mice exacerbated psoriasis. Testosterone inhibited both in vitro Th17 differentiation and in vivo IL‐17 expression, correlating with reduced psoriasis severity. Molecular studies indicated that testosterone is an inverse agonist of related orphan receptor gamma (RORγt), a key transcription factor for IL‐17 expression. These findings offer mechanistic insights into how testosterone limits tissue inflammation in psoriasis and suggest a basis for developing novel testosterone derivatives to target RORγt and suppress Th17‐mediated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 1, Group F, Member 3TestosteroneInterleukin-17Th17 CellsPsoriasisAnimalsMiceMaleFemaleCell DifferentiationDisease Models, AnimalMice, Inbred C57BLImiquimodHumans

Stichwörter der Autor:innen

IL‐17 | immune sex bias | immune sex dimorphism | psoriasis | testosterone | Th…

Substanzen

Nuclear Receptor Subfamily 1, Group F, Member 3TestosteroneInterleukin-17Imiquimod

Autor:innen und Institutionen

  • Immunology Core Laboratory, Translational Health Science and Technology Institute, Faridabad, India.
  • Centre for Immunobiology and Immunotherapy, Translational Health Science and Technology Institute, Faridabad, India.
  • Translational Health Science and Technology Institute, Faridabad, India.

ORCID-Profile: Akshay Binayke, Amit Awasthi

Förderung

  • Translational Health Science and Technology Institute

Zitieren

APA

Binayke, A., Dalal, R., Suri, C., Dandotiya, J., Sadhu, S., Kumar, Y., Asthana, S., Rathore, D. K., & Awasthi, A. (2025). Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions. European Journal of Immunology. https://doi.org/10.1002/eji.70016

Vancouver

Binayke A, Dalal R, Suri C, Dandotiya J, Sadhu S, Kumar Y, et al. Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions. European Journal of Immunology. 2025. doi:10.1002/eji.70016

BibTeX
@article{Binayke2025,
  author = {Binayke, Akshay and Dalal, Rajdeep and Suri, Charu and Dandotiya, Jyotsna and Sadhu, Srikanth and Kumar, Yashwant and Asthana, Shailendra and Rathore, Deepak Kumar and Awasthi, Amit},
  title = {Testosterone Suppresses IL‐17 Expression by Targeting RORγt Functions},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.70016}
}
Kostenlos starten →